Search
for
Sort by
Research 211–240 of 859
- Metabolic risk in PCOS: phenotype and adiposity impact
- Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Congenital Adrenal Hyperplasia
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Health and fertility in World Health Organization group 2 anovulatory women
- Polycystic Ovary Syndrome
- Diagnosis of hyperandrogenism: clinical criteria
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Diagnosis of hyperandrogenism: Biochemical criteria
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- PCOS in adolescents
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Androgens in women